19 November 2026 re-tender around October 2026 |
Dostawy produktów leczniczych
Warmińsko-Mazurskie Centrum Chorób Płuc w Olsztynie |
Roche Polska Urtica Amgen AstraZeneca Kft Farmacol-Logistyka 4 bids received |
– |
2 February 2027 re-tender around October 2026 |
Expediente 2204/2025, nº siglo 578/2025, cca +6.i+e9q8j contr bam 2026 208764, con la empresa amgen, s.a
Servicio Andaluz de Salud. Hospital Universitario Puerta del Mar framework agreement |
AMGEN, S.A 1 bid received |
€7,780,208 |
20 March 2027 re-tender around October 2026 |
Langwerkende en kortwerkende Filgrastim
UZ Leuven framework agreement |
sandoz ACCORD HEALTHCARE Teva Pharma Belgium AMGEN NV 4 bids received |
€11,618,058 |
11 May 2027 re-tender around November 2026 |
Acuerdo Marco Suministro (CONTR 2025 0000563560)
Servicio Andaluz de Salud. Complejo Hospitalario Torrecárdenas. framework agreement |
AMGEN, S.A. BIOGEN SPAIN, S.L. SANDOZ FARMACEUTICA, S.A. ACCORD HEALTHCARE, SLU BIOCON BIOLOGICS SPAIN, S.L. FRESENIUS KABI ESPAÑA, S.A. JANSSEN-CILAG, S.A. LABORATORIO STADA, S.L. 46 bids received |
€7,943,663 |
29 June 2027 re-tender around December 2026 |
La contratación, mediante Acuerdo Marco con varios empresarios, del suministro sucesivo de diversos medicamentos para el tratamiento del mieloma múltiple para los centros hospitalarios del Servizo Galego de Saúde
Servizo Galego de Saúde framework agreement |
AMGEN, S.A JANSSEN-CILAG, S.A. SANOFI-AVENTIS, S.A. PFIZER S. L.U 1 bid received |
€59,539,295 |
29 June 2027 re-tender around December 2026 |
Adjudicación del Contrato Específico del Medicamento USTEKINUMAB, derivado del Sistema Dinámico de Adquisición del Suministro de Medicamentos Exclusivos, para el HOSPITAL OLOT COMARCAL GARROTXA
Fundació Hospital d'Olot i Comarcal de la Garrotxa |
AMGEN SA 2 bids received |
€249,366 |
14 October 2027 re-tender around April 2027 |
2026-171 CB Suministro de medicamentos para el tratamiento de la hipercolesterolemia primaria (familiar heterocigótica y no familiar) o displidemia mixta con inhibidores de PCSK9.
Consorci Hospital Clínic de Barcelona (HCB) framework agreement |
AMGEN, S.A. SANOFI-AVENTIS, S.A. 2 bids received |
€1,306,402 |
9 November 2027 re-tender around May 2027 |
Leveren van een terugbetaalde vorm van Bevacizumab 100 mg/4 ml en 400 mg/ 16ml voor intraveneus gebruik
UZ Leuven framework agreement |
AMGEN Celltrion Healthcare Netherlands B.V. EG 3 bids received |
€2,943,059 |
2 May 2028 re-tender around November 2027 |
Fourniture d'eculizumab 2024-2028
HUmani SC framework agreement |
AMGEN NV 1 bid received |
€1,470,000 |
18 May 2028 re-tender around November 2027 |
CBAM 578/2025 AMGEN/01
SERVICIO ANDALUZ DE SALUD. HOSPITAL UNIVERSITARIO REGIONAL DE MÁLAGA |
AMGEN, S.A. 1 bid received |
€673,077 |
27 November 2028 re-tender around May 2028 |
Raamovereenkomst voor levering van Eculizumab
Onze-Lieve-Vrouwziekenhuis v.z.w. (met campussen te Aalst, Asse en Ninove) framework agreement |
Amgen n.v. 2 bids received |
€2,000,000 |
1 January 2029 re-tender around July 2028 |
Raamkomst voor het leveren van langwerkende Erythropoëtines
A.S.Z. Autonome Verzorgingsinstelling framework agreement |
AMGEN NV 1 bid received |
€2,876,574 |
9 April 2029 re-tender around October 2028 |
Aankoop en levering van epoëtine met verlengde werkingsduur
Algemeen Ziekenhuis Sint-Maria vzw framework agreement |
AMGEN NV 1 bid received |
€464,640 |
17 July 2029 re-tender around January 2029 |
Darbepoëtine en romiplostim
AZ Delta vzw framework agreement |
Amgen NV 1 bid received |
€5,010,715 |